Belgium, the Czech Republic, Estonia, Germany, Hungary, Latvia, the Netherlands, the Slovak Republic, Slovenia and Sweden have notified UNEP that use of CFCs is not considered essential for the manufacture of MDIs for placing on the market of the European Community that contain the active ingredients belonging to the therapeutic category of inhaled steroids, specifically beclomethasone, dexamethasone, flunisolide, fluticasone, budesonide and triamcinolone
En op een goeie dag... zul je ons een toekomst gevenoj4 oj4